Suppliers / Vuab Pharma

Vuab Pharma

Czech Republic Updated 9 July 2026

Vuab Pharma is an API manufacturer based in Czech Republic. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Nystatin US FDA 1
Oxaliplatin US FDA 1

Also appears on these molecule pages

Nystatin API Oxaliplatin API

Questions about Vuab Pharma

Does Vuab Pharma hold a US DMF or a CEP?
Vuab Pharma holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Vuab Pharma make?
2 molecules are on record against Vuab Pharma, including Nystatin and Oxaliplatin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Vuab Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Cipla shares 1 molecule Laurus Labs shares 1 molecule Shilpa Pharma Lifesciences shares 1 molecule Veranova Lp shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability